Clinical Trial Update: Safety and Efficacy Study of Sublingual Immunotherapy (SLIT) to Treat House Dust Mite Allergic Rhinitis in Adolescents and Children [Phase 3]

View source ↗

Summary

A Phase 3 trial assessing the safety and efficacy of house dust mite Sublingual Immunotherapy (SLIT) for allergic rhinitis in children and adolescents; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• House Dust Mite Sublingual Immunotherapy (Sublingual immunotherapy extract for dust mite)

Snippet

Sponsor: Stallergenes Greer | Conditions: Allergic Rhinitis Due to Dust Mite | Phase 3 | Status: TERMINATED | Results posted: 2025-02-11